astrazeneca ab - tezepelumab - astma - läkemedel mot obstruktiv lungsjukdom, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)